Atika Capital Management’s STAAR Surgical STAA Stock Holding History

Atika Capital Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,000	Closed	-$5.26M	–	98
2023 Q2	$5.26M	Buy	+1,000	New	+$60.9K	0.53%	64

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atika Capital Management's STAA Position: Q4 2025 in Review

Atika Capital Management sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 16,400 shares — an estimated $441K sold.

Atika Capital Management first reported a position in STAA in Q2 2025 and held it in 2 quarters. The position peaked at $441K in Q3 2025. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

Atika Capital Management reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
Atika Capital Management sold 16,400 STAAR Surgical shares in Q4 2025, an estimated $441K.
Atika Capital Management first reported a position in STAAR Surgical in Q2 2025 and held it in 2 quarters.
Atika Capital Management's STAAR Surgical position peaked at $441K in Q3 2025.
201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Atika Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.